Das Deutsche Herzzentrum Berlin ist eine überregionale Spezialklinik für Diagnostik und Therapie bei Herz-Kreislauf-Erkrankungen im Bezirk Mitte von Berlin. Es verfügt über fünf Kliniken und 196 Betten, davon 71 für Intensivbehandlung. Anfang 1986 erfolgte die Betriebsaufnahme.

During the past decade, Deutsches Herzzentrum Berlin conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 25 clinical trials were completed, i.e. on average, 34.7% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 11 clinical trials were completed. i.e. 39.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deutsches Herzzentrum Berlin" #1 sponsor was "German Heart Institute" with 15 trials, followed by "Abbott Medical Devices" with 13 trials sponsored, "Boston Scientific Corporation" with 9 trials sponsored, "Competence Network for Congenital Heart Defects" with 6 trials sponsored and "Edwards Lifesciences" with 6 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 66 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deutsches Herzzentrum Berlin" #1 collaborator was "German Federal Ministry of Education and Research" with 7 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 5 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 5 trials as a collaborator, "Charite University, Berlin, Germany" with 3 trials as a collaborator and "German Heart Center" with 3 trials as a collaborator. Other collaborators include 174 different institutions and companies that were collaborators in the rest 171 trials.

According to Clinical.Site data, the most researched conditions in "Deutsches Herzzentrum Berlin" are "Heart Failure" (16 trials), "Aortic Valve Stenosis" (14 trials), "Coronary Artery Disease" (6 trials), "Cardiovascular Disease" (5 trials) and "Heart Valve Diseases" (5 trials). Many other conditions were trialed in "Deutsches Herzzentrum Berlin" in a lesser frequency.

Most popular intervention types in "Deutsches Herzzentrum Berlin" are "Device" (74 trials), "Drug" (20 trials), "Procedure" (12 trials), "Diagnostic Test" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "HAART 300 Annuloplasty Device" (2 trials), "JenaValve Pericardial TAVR System" (2 trials), "Tendyne Mitral Valve System" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Deutsches Herzzentrum Berlin" are 125 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Deutsches Herzzentrum Berlin". undefined are not yet recruiting, 25 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 54 completed trials in Deutsches Herzzentrum Berlin, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Deutsches Herzzentrum Berlin, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 45 trials that are defined as “Not Applicable".

Deutsches Herzzentrum Berlin has several departments that took part in Clinical trials: "Herzzentrum Berlin, Ped Cardiology" - 2 trials